Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 215

1.

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.

Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, Martinelli G, Veglia F, Fiorentini C, Cipolla CM.

Circulation. 2006 Dec 5;114(23):2474-81. Epub 2006 Nov 13.

PMID:
17101852
[PubMed - indexed for MEDLINE]
Free Article
2.
3.

Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.

Exner DV, Dries DL, Domanski MJ, Cohn JN.

N Engl J Med. 2001 May 3;344(18):1351-7.

PMID:
11333991
[PubMed - indexed for MEDLINE]
Free Article
4.

Early treatment with low-dose enalapril after acute myocardial infarction: an equilibrium radionuclide angiographic study. Enalapril despues del Infarto (EDI) Trial Investigators.

Bazzino O, Navarro Estrada JL, Sosa Liprandi A, Presti C, Masoli O, Santopinto J, Ahuad A, Amuchástegui M, Méndez R.

J Nucl Cardiol. 1997 Mar-Apr;4(2 Pt 1):133-9.

PMID:
9115065
[PubMed - indexed for MEDLINE]
5.

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy.

Cardinale D, Sandri MT, Martinoni A, Tricca A, Civelli M, Lamantia G, Cinieri S, Martinelli G, Cipolla CM, Fiorentini C.

J Am Coll Cardiol. 2000 Aug;36(2):517-22.

PMID:
10933366
[PubMed - indexed for MEDLINE]
6.

Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.

Colucci WS, Kolias TJ, Adams KF, Armstrong WF, Ghali JK, Gottlieb SS, Greenberg B, Klibaner MI, Kukin ML, Sugg JE; REVERT Study Group.

Circulation. 2007 Jul 3;116(1):49-56. Epub 2007 Jun 18.

PMID:
17576868
[PubMed - indexed for MEDLINE]
Free Article
7.

Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction.

Patten RD, Kronenberg MW, Benedict CR, Udelson JE, Kinan D, Stewart D, Yusuf S, Smith JJ, Kilcoyne L, Dolan N, Edens TR, Metherall J, Konstam MA.

Am Heart J. 1997 Jul;134(1):37-43.

PMID:
9266781
[PubMed - indexed for MEDLINE]
8.

Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy.

Cardinale D, Sandri MT, Martinoni A, Borghini E, Civelli M, Lamantia G, Cinieri S, Martinelli G, Fiorentini C, Cipolla CM.

Ann Oncol. 2002 May;13(5):710-5.

PMID:
12075738
[PubMed - indexed for MEDLINE]
Free Article
9.

Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy.

Cardinale D, Sandri MT, Colombo A, Colombo N, Boeri M, Lamantia G, Civelli M, Peccatori F, Martinelli G, Fiorentini C, Cipolla CM.

Circulation. 2004 Jun 8;109(22):2749-54. Epub 2004 May 17.

PMID:
15148277
[PubMed - indexed for MEDLINE]
Free Article
10.

Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity.

Civelli M, Cardinale D, Martinoni A, Lamantia G, Colombo N, Colombo A, Gandini S, Martinelli G, Fiorentini C, Cipolla CM.

Int J Cardiol. 2006 Jul 28;111(1):120-6. Epub 2005 Oct 20.

PMID:
16242796
[PubMed - indexed for MEDLINE]
11.

Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients.

Dries DL, Strong MH, Cooper RS, Drazner MH.

J Am Coll Cardiol. 2002 Jul 17;40(2):311-7. Erratum in: J Am Coll Cardiol 2002 Sep 4;40(5):1019.

PMID:
12106937
[PubMed - indexed for MEDLINE]
12.

Evaluation of enalapril+losartan treatment with cardiopulmonary exercise test in patients with left ventricular dysfunction.

Akbulut T, Akgöz H, Dayi SU, Celik SE, Gürkan U, Tayyareci G.

Angiology. 2006 Mar-Apr;57(2):181-6.

PMID:
16518525
[PubMed - indexed for MEDLINE]
13.

Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction.

Guazzi M, Melzi G, Marenzi GC, Agostoni P.

Clin Pharmacol Ther. 1999 Mar;65(3):319-27.

PMID:
10096264
[PubMed - indexed for MEDLINE]
14.

Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.

de Bree E, van Ruth S, Schotborgh CE, Baas P, Zoetmulder FA.

Ann Surg Oncol. 2007 Oct;14(10):3019-26. Epub 2007 Jul 20.

PMID:
17638057
[PubMed - indexed for MEDLINE]
15.

Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction.

Capes SE, Gerstein HC, Negassa A, Yusuf S.

Diabetes Care. 2000 Mar;23(3):377-80.

PMID:
10868869
[PubMed - indexed for MEDLINE]
Free Article
16.

Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?

Granger CB.

Circulation. 2006 Dec 5;114(23):2432-3. No abstract available. Erratum in: Circulation. 2007 Jan 16;115(2):e31.

PMID:
17146002
[PubMed - indexed for MEDLINE]
Free Article
17.

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR.

Clin Ther. 2007 Sep;29(9):1803-24. Review.

PMID:
18035185
[PubMed - indexed for MEDLINE]
18.

Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).

Vermes E, Ducharme A, Bourassa MG, Lessard M, White M, Tardif JC; Studies Of Left Ventricular Dysfunction.

Circulation. 2003 Mar 11;107(9):1291-6.

PMID:
12628950
[PubMed - indexed for MEDLINE]
Free Article
19.

Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction.

Maia LN, Nicolau JC, Vítola JV, Santos M, Brandi JM, Joaquim MR, Baggi JM Jr, Cordeiro JA, de Godoy MF.

Am Heart J. 2003 Jun;145(6):E21.

PMID:
12796769
[PubMed - indexed for MEDLINE]
20.

Minor increases in plasma troponin I predict decreased left ventricular ejection fraction after high-dose chemotherapy.

Sandri MT, Cardinale D, Zorzino L, Passerini R, Lentati P, Martinoni A, Martinelli G, Cipolla CM.

Clin Chem. 2003 Feb;49(2):248-52.

PMID:
12560347
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk